METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA

METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA

The invention features methods for characterizing and treating acute myeloid leukemia (AML) (e.g., newly diagnosed, relapsed, and refractory AML) in a subject using immunoconjugates of the invention. In one aspect, the invention generally features a method of treating acute myeloid leukemia in a sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NOORDHUIS, PAUL, WALKER, RUSSELL MARLIN, WHITEMAN, KATHLEEN R, LUTZ, ROBERT J, SCHUURHUIS, GERRIT JAN, KOVTUN, YELENA
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NOORDHUIS, PAUL
WALKER, RUSSELL MARLIN
WHITEMAN, KATHLEEN R
LUTZ, ROBERT J
SCHUURHUIS, GERRIT JAN
KOVTUN, YELENA
description The invention features methods for characterizing and treating acute myeloid leukemia (AML) (e.g., newly diagnosed, relapsed, and refractory AML) in a subject using immunoconjugates of the invention. In one aspect, the invention generally features a method of treating acute myeloid leukemia in a subject (e.g., a human), the method involving administering an effective amount of an immunoconjugate to a pre-selected subject, where the immunoconjugate contains a humanized or chimeric antibody or fragment conjugated to a cytotoxic benzodiazepine dimer compound via a cleavable disulfide linker. L'invention concerne des procédés permettant de caractériser et de traiter la leucémie myéloïde aiguë (LMA) (par exemple, une LMA nouvellement diagnostiquée, en récidive et réfractaire) chez un sujet au moyen des immunoconjugués de l'invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2015179400A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2015179400A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2015179400A33</originalsourceid><addsrcrecordid>eNrjZLDzdQ3x8HcJVnDzD1Jw9nAMcnQOcQ3yjPL0c1dw9HNRCAlydQwBc5xDQ1wVfCNdffw9XRR8XEO9XX09HXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBoamhuaWJgYGjsTFxqgD9_Cr_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA</title><source>esp@cenet</source><creator>NOORDHUIS, PAUL ; WALKER, RUSSELL MARLIN ; WHITEMAN, KATHLEEN R ; LUTZ, ROBERT J ; SCHUURHUIS, GERRIT JAN ; KOVTUN, YELENA</creator><creatorcontrib>NOORDHUIS, PAUL ; WALKER, RUSSELL MARLIN ; WHITEMAN, KATHLEEN R ; LUTZ, ROBERT J ; SCHUURHUIS, GERRIT JAN ; KOVTUN, YELENA</creatorcontrib><description>The invention features methods for characterizing and treating acute myeloid leukemia (AML) (e.g., newly diagnosed, relapsed, and refractory AML) in a subject using immunoconjugates of the invention. In one aspect, the invention generally features a method of treating acute myeloid leukemia in a subject (e.g., a human), the method involving administering an effective amount of an immunoconjugate to a pre-selected subject, where the immunoconjugate contains a humanized or chimeric antibody or fragment conjugated to a cytotoxic benzodiazepine dimer compound via a cleavable disulfide linker. L'invention concerne des procédés permettant de caractériser et de traiter la leucémie myéloïde aiguë (LMA) (par exemple, une LMA nouvellement diagnostiquée, en récidive et réfractaire) chez un sujet au moyen des immunoconjugués de l'invention.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160204&amp;DB=EPODOC&amp;CC=WO&amp;NR=2015179400A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160204&amp;DB=EPODOC&amp;CC=WO&amp;NR=2015179400A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NOORDHUIS, PAUL</creatorcontrib><creatorcontrib>WALKER, RUSSELL MARLIN</creatorcontrib><creatorcontrib>WHITEMAN, KATHLEEN R</creatorcontrib><creatorcontrib>LUTZ, ROBERT J</creatorcontrib><creatorcontrib>SCHUURHUIS, GERRIT JAN</creatorcontrib><creatorcontrib>KOVTUN, YELENA</creatorcontrib><title>METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA</title><description>The invention features methods for characterizing and treating acute myeloid leukemia (AML) (e.g., newly diagnosed, relapsed, and refractory AML) in a subject using immunoconjugates of the invention. In one aspect, the invention generally features a method of treating acute myeloid leukemia in a subject (e.g., a human), the method involving administering an effective amount of an immunoconjugate to a pre-selected subject, where the immunoconjugate contains a humanized or chimeric antibody or fragment conjugated to a cytotoxic benzodiazepine dimer compound via a cleavable disulfide linker. L'invention concerne des procédés permettant de caractériser et de traiter la leucémie myéloïde aiguë (LMA) (par exemple, une LMA nouvellement diagnostiquée, en récidive et réfractaire) chez un sujet au moyen des immunoconjugués de l'invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDzdQ3x8HcJVnDzD1Jw9nAMcnQOcQ3yjPL0c1dw9HNRCAlydQwBc5xDQ1wVfCNdffw9XRR8XEO9XX09HXkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBoamhuaWJgYGjsTFxqgD9_Cr_</recordid><startdate>20160204</startdate><enddate>20160204</enddate><creator>NOORDHUIS, PAUL</creator><creator>WALKER, RUSSELL MARLIN</creator><creator>WHITEMAN, KATHLEEN R</creator><creator>LUTZ, ROBERT J</creator><creator>SCHUURHUIS, GERRIT JAN</creator><creator>KOVTUN, YELENA</creator><scope>EVB</scope></search><sort><creationdate>20160204</creationdate><title>METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA</title><author>NOORDHUIS, PAUL ; WALKER, RUSSELL MARLIN ; WHITEMAN, KATHLEEN R ; LUTZ, ROBERT J ; SCHUURHUIS, GERRIT JAN ; KOVTUN, YELENA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2015179400A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>NOORDHUIS, PAUL</creatorcontrib><creatorcontrib>WALKER, RUSSELL MARLIN</creatorcontrib><creatorcontrib>WHITEMAN, KATHLEEN R</creatorcontrib><creatorcontrib>LUTZ, ROBERT J</creatorcontrib><creatorcontrib>SCHUURHUIS, GERRIT JAN</creatorcontrib><creatorcontrib>KOVTUN, YELENA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NOORDHUIS, PAUL</au><au>WALKER, RUSSELL MARLIN</au><au>WHITEMAN, KATHLEEN R</au><au>LUTZ, ROBERT J</au><au>SCHUURHUIS, GERRIT JAN</au><au>KOVTUN, YELENA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA</title><date>2016-02-04</date><risdate>2016</risdate><abstract>The invention features methods for characterizing and treating acute myeloid leukemia (AML) (e.g., newly diagnosed, relapsed, and refractory AML) in a subject using immunoconjugates of the invention. In one aspect, the invention generally features a method of treating acute myeloid leukemia in a subject (e.g., a human), the method involving administering an effective amount of an immunoconjugate to a pre-selected subject, where the immunoconjugate contains a humanized or chimeric antibody or fragment conjugated to a cytotoxic benzodiazepine dimer compound via a cleavable disulfide linker. L'invention concerne des procédés permettant de caractériser et de traiter la leucémie myéloïde aiguë (LMA) (par exemple, une LMA nouvellement diagnostiquée, en récidive et réfractaire) chez un sujet au moyen des immunoconjugués de l'invention.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2015179400A3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title METHODS FOR CHARACTERIZING AND TREATING ACUTE MYELOID LEUKEMIA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A25%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NOORDHUIS,%20PAUL&rft.date=2016-02-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2015179400A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true